Home > Drugs A – Z > Fluorometholone (Into the eye)

Fluorometholone (Into the eye)

Treats eye inflammation. This medicine is a corticosteroid (steroid medicine).

What works?

Learn more about the effects of these drugs. The most reliable research is summed up for you in our featured article.

Fluorometholone is used to treat eye conditions caused by inflammation (swelling). This medicine is a corticosteroid (steroid medicine) that helps reduce the swelling in the eye. This medicine is available only with your doctor's prescription… Read more
Brand names include
FML Forte Liquifilm, FML S.O.P., Flarex, Fluor-OP, Fml Forte, Fml Liquifilm, Pms-Fluorometholone
Drug classes About this
Ophthalmologic Agent

What works? Research summarized

Evidence reviews

Crohn's Disease: Management in Adults, Children and Young People

This guideline intends to show the place of both new and established treatments in the wider care pathway for Crohn's disease. This will be useful for clinicians and people with Crohn's disease because new drugs have been licensed for Crohn's disease in the last decade. The guideline also deals with those medications which are unlicensed for treatment of the condition, but which have been used in this way (off-label) for many years and their role is recognised in other NICE documents as well as the British National Formulary. They include azathioprine, mercaptopurine and methotrexate. The guideline aims to help improve the care offered to people with Crohn's disease and provide information about the clinical and cost effectiveness of potential care pathways. Management of Crohn's disease in specific populations (for example, in pregnancy) may require special consideration.

Bacterial Meningitis and Meningococcal Septicaemia: Management of Bacterial Meningitis and Meningococcal Septicaemia in Children and Young People Younger than 16 Years in Primary and Secondary Care

This guideline covers bacterial meningitis and meningococcal septicaemia, focusing on management of these conditions in children and young people aged younger than 16 years in primary and secondary care, and using evidence of direct relevance to these age groups where available.

End of Life Care for Infants, Children and Young People with Life-Limiting Conditions: Planning and Management

This guideline covers the physical, emotional, social and spiritual elements of end of life care, and focuses on improving the child or young person’s quality of life and supporting their family and carers. There are, for instance, recommendations on managing distressing symptoms and providing care and bereavement support after death. Recommendations have also been made about how services should be delivered. The guideline is aimed at all providers of paediatric end of life care, whatever their level of practise, and also for children and young people with life-limiting conditions and their parents or carers.

See all (4)

PubMed Health Blog...

read all...